AI Portfolio Summary
In 2018 Q3, Clarus Ventures, LLC maintained a portfolio of 10 distinct positions. The most significant new addition to the portfolio was Gritstone Oncology I, which now represents 8.59% of the total fund value. They heavily accumulated shares in Nanostring Technolog, increasing their position by 1.9%.
Total Positions
10
Quarter
2018 Q3
Top Holding
N/A (36.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-10 of 10
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
AvroBio Inc.
|
—
|
Unknown | 36.11% | 30.09% |
#1
Prev: #1
|
10.0 | no change | no change |
P
S
|
2,962,325 | $153,656,000 | — | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | ||
|
NSTG
Nanostring Tech...
|
Unknown | 16.91% | 19.27% |
#2
1
Prev: #3
|
8.8 | 76,585 | 1.9% |
P
S
|
4,036,025 | $71,962,000 | 2013 Q4 | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | |||
|
SIEN
Sientra Inc.
|
Unknown | 15.33% | 18.95% |
#3
1
Prev: #4
|
6.1 | no change | no change |
P
S
|
2,730,765 | $65,211,000 | 2014 Q4 | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | |||
|
FTSV
Forty Seven Inc
|
Unknown | 13.38% | 21.72% |
#4
2
Prev: #2
|
5.4 | no change | no change |
P
S
|
3,816,951 | $56,949,000 | 2018 Q2 | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | |||
|
N/A
Gritstone Oncol...
|
—
|
Unknown | 8.59% | — |
#5
Prev: #—
|
5.4 | 2,567,445 | no change |
NEW
|
2,567,445 | $36,560,000 | — | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | ||
|
N/A
Entasis Therape...
|
—
|
Unknown | 4.15% | — |
#6
Prev: #—
|
3.7 | 1,623,405 | no change |
NEW
|
1,623,405 | $17,663,000 | — | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | ||
|
N/A
Restoration Rob...
|
—
|
Unknown | 2.43% | 4.41% |
#7
2
Prev: #5
|
1.0 | no change | no change |
P
S
|
3,569,986 | $10,353,000 | — | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | ||
|
VAC
VBI Vaccines In...
|
Consumer Cyclical | 1.53% | 2.63% |
#8
2
Prev: #6
|
0.6 | no change | no change |
P
S
|
2,691,042 | $6,512,000 | 2016 Q2 | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | |||
|
EPIX
ESSA Pharma Inc...
|
Unknown | 1.18% | 2.25% |
#9
2
Prev: #7
|
0.5 | no change | no change |
P
S
|
1,668,560 | $5,006,000 | 2018 Q2 | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) | |||
|
N/A
Catabasis Pharm...
|
—
|
Unknown | 0.38% | 0.68% |
#10
2
Prev: #8
|
0.2 | no change | no change |
P
S
|
2,008,192 | $1,606,000 | — | 13F Filing | 2018-09-30 | 2018-11-14 (Est.) |
Showing 1-10 of 10 holdings